Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol

Table 1 Schedule of Events for Multi-site Observational Maternal and Infant COVID-19 Vaccine Study (MOMI-Vax). Schedule of Events: Pregnant Women and their Infants^a

Abbreviations: mL milliliters
^an = approximately 200 pregnant women who are scheduled to receive or have completed any licensed or EUA COVID-19 vaccine series per vaccine type and approximately 200 infants born to pregnant women per vaccine type
^bOnly applicable if V01 was completed pre-vaccination

ISSN: 1471-2393